Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 1999;30:1764-1771

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iso, H.
Right arrow Articles by Manson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iso, H.
Right arrow Articles by Manson, J. E.
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Acute Stroke Syndromes
Right arrow Primary and Secondary Stroke Prevention

(Stroke. 1999;30:1764-1771.)
© 1999 American Heart Association, Inc.

Original Contributions

Prospective Study of Aspirin Use and Risk of Stroke in Women

Hiroyasu Iso, MD; Charles H. Hennekens, MD; Meir J. Stampfer, MD; Kathryn M. Rexrode, MD; Graham A. Colditz, MBBS; Frank E. Speizer, MD; Walter C. Willett, MD JoAnn E. Manson, MD

From Channing Laboratory (H.I., M.J.S., K.M.R., G.A.C., F.E.S., W.C.W., J.E.M.) and the Division of Preventive Medicine (C.H.H., K.M.R., J.E.M.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and the Departments of Epidemiology (C.H.H., M.J.S., G.A.C., W.C.W., J.E.M.) and Nutrition (M.J.S., W.C.W.), Harvard School of Public Health, Boston, Mass.

Correspondence to JoAnn E. Manson, MD, Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Ave East, Boston, MA 02215. E-mail jmanson{at}rics.bwh.harvard.edu

Background and Purpose—In secondary prevention, aspirin reduces risk of ischemic stroke. In primary prevention of stroke, however, the role of aspirin is uncertain, especially in women.

Methods—In 1980, 79 319 women in the Nurses' Health Study cohort, 34 to 59 years of age and free of diagnosed cardiovascular disease, cancer, and rheumatoid arthritis, completed questionnaires that included information on aspirin use. Data on aspirin use were updated in 1982, 1984, and 1988. By 1994, after 994 231 person-years of follow-up, 503 incident strokes (295 ischemic strokes, 100 subarachnoid hemorrhages, 52 intraparenchymal hemorrhages, and 56 strokes of undetermined type) were documented.

Results—There was no clear relationship between aspirin use and risk of total stroke; risk was slightly reduced among women who took 1 to 6 aspirin per week and slightly increased among women who took 7 or more aspirin per week. Women who took 1 to 6 aspirin per week had a lower risk of large-artery occlusive infarction compared with women who reported no aspirin use; after simultaneous adjustment for other cardiovascular risk factors and selected nutrients, the multivariate relative risk was 0.50 (95% CI 0.29 to 0.85, P=0.01). Women who took 15 or more aspirin per week had an excess risk of subarachnoid hemorrhage; the multivariate relative risk was 2.02 (95% CI 1.04 to 3.91, P for trend=0.02). The reduction in large-artery occlusive infarction with aspirin was of greater magnitude for older, hypertensive, or smoking women than for younger, nonhypertensive, or nonsmoking women; the elevation in subarachnoid hemorrhage with aspirin was also more apparent for older or hypertensive women than for younger or nonhypertensive women. Aspirin use was not associated with risk of other subtypes of stroke.

Conclusions—These prospective data indicate that women who take 1 to 6 aspirin per week have a reduced risk of large-artery occlusive infarction, but those who use 15 or more aspirin per week have an increased risk of subarachnoid hemorrhage. This observational study suggests benefits of aspirin for ischemic stroke with low frequency of use and hazards for hemorrhagic stroke with high frequency of use, particularly among older or hypertensive women. Thus, the effect on total stroke will depend on the dose of aspirin and the distribution of stroke subtypes and risk factors in the population.


Key Words: aspirin • prevention, primary • stroke • stroke classification




This article has been cited by other articles:


Home page
 ChestHome page
C. Patrono, C. Baigent, J. Hirsh, and G. Roth
Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 199S - 233S.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. T. Chan, J. E. Manson, D. Feskanich, M. J. Stampfer, G. A. Colditz, and C. S. Fuchs
Long-term Aspirin Use and Mortality in Women
Arch Intern Med, March 26, 2007; 167(6): 562 - 572.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. T. Chan, J. E. Manson, C. M. Albert, C. U. Chae, K. M. Rexrode, G. C. Curhan, E. B. Rimm, W. C. Willett, and C. S. Fuchs
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Circulation, March 28, 2006; 113(12): 1578 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
P. N. Papanikolaou, G. D. Christidi, and J. P.A. Ioannidis
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
Can. Med. Assoc. J., February 28, 2006; 174(5): 635 - 641.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. T. Chan, E. L. Giovannucci, J. A. Meyerhardt, E. S. Schernhammer, G. C. Curhan, and C. S. Fuchs
Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer
JAMA, August 24, 2005; 294(8): 914 - 923.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Patrono, B. Coller, G. A. FitzGerald, J. Hirsh, and G. Roth
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 234S - 264S.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. T. Chan, E. L. Giovannucci, E. S. Schernhammer, G. A. Colditz, D. J. Hunter, W. C. Willett, and C. S. Fuchs
A Prospective Study of Aspirin Use and the Risk for Colorectal Adenoma
Ann Intern Med, February 3, 2004; 140(3): 157 - 166.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
M. H. Parker
A Review of Cardiovascular Disease and Treatment Differences in Women
Journal of Pharmacy Practice, June 1, 2003; 16(3): 157 - 163.
[Abstract] [PDF]

Home page
 ChestHome page
C. Patrono, B. Coller, J. E. Dalen, G. A. FitzGerald, V. Fuster, M. Gent, J. Hirsh, and G. Roth
Platelet-Active Drugs : The Relationships Among Dose, Effectiveness, and Side Effects
Chest, January 1, 2001; 119(1_suppl): 39S - 63S.
[Full Text] [PDF]

Home page
 BMJHome page
L. E Ramsay, P. S Sanmuganathan, E. J Wallis, P. R Jackson, and A. Alkhenizan
Aspirin for primary prevention
BMJ, December 9, 2000; 321(7274): 1472 - 1472.
[Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-W. Yang, J. Wang, T. Zheng, B. T. Altura, and B. M. Altura
Low [Mg2+]o induces contraction and [Ca2+]i rises in cerebral arteries: roles of Ca2+, PKC, and PI3
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2898 - H2907.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
Other articles noted
Evid. Based Nurs., October 1, 2000; 3(4): 106 - 112.
[Full Text]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.